Top Markets
#1 龙虾 (Lobster) 龙虾 (Lobster) +64.00%
#2 SODAX SODAX +50.99%
#3 Cortex Cortex +32.55%
#4 DexNet DexNet +23.19%
#5 Pons Pons +20.53%
#6 Akedo Akedo +20.13%
#7 wojak wojak +18.06%
#8 OpenEden OpenEden +15.28%
#9 Orbs Orbs +14.71%
#10 APEX APEX +13.93%
Coin of the day
龙虾 (Lobster) 龙虾 (Lobster)
Settings
Language
ENGLISH
Currency
USD
Theme
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Rank in Stocks #7324
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Share Price
$36.75
Last synced: 2026-08-27
Market Cap
$1.63B
Change (1 day)
-0.78%
Change (1 year)
-
Country
US
Trade Avalyn Pharma Inc. Common Stock (AVLN)

Category

Healthcare
P/S ratio for Avalyn Pharma Inc. Common Stock (AVLN)
P/S ratio as of 2026 TTM: 0
According to Avalyn Pharma Inc. Common Stock latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Avalyn Pharma Inc. Common Stock from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH